Serological diagnosis of secondary syphilis in a Rituximab-treated patient: an emerging diagnostic challenge?
J Eur Acad Dermatol Venereol
.
2021 May;35(5):e350-e352.
doi: 10.1111/jdv.17126.
Epub 2021 Feb 5.
Authors
C Lefeuvre
1
,
A Croué
2
,
P Abgueguen
3
,
M Letzelter
4
,
A Ducancelle
1
,
P Grange
5
,
N Benhaddou
5
,
N Dupin
5
,
H Le Guillou-Guillemette
1
,
C Le Clec'h
4
Affiliations
1
Virology Department, Angers University Hospital, Angers, France.
2
Pathology Department, Angers University Hospital, Angers, France.
3
Infectious Diseases Department, Angers University Hospital, Angers, France.
4
Dermatology Department, Angers University Hospital, Angers, France.
5
French National Reference Center for Syphilis, Cochin University Hospital, Paris, France.
PMID:
33462864
DOI:
10.1111/jdv.17126
No abstract available
Publication types
Letter
MeSH terms
Humans
Rituximab / adverse effects
Syphilis Serodiagnosis
Syphilis* / diagnosis
Syphilis* / drug therapy
Substances
Rituximab
Supplementary concepts
Syphilis, secondary